RapidFlow

AWS GraphRAG deployment cuts drug research cycles by 87%, turning six months of discovery into three weeks

Category: Healthcare AI

What it is

A GraphRAG deployment built on Amazon Neptune Analytics and Bedrock
reduced pharmaceutical research and development cycles by 87%. The system
connects previously siloed proprietary databases – clinical metrics, lab notes,
engineering data – into a unified, queryable knowledge graph, preventing lost
context when staff leave active projects. Initial discovery phases dropped from six
months to three weeks, data retrieval speed improved 85%, and research review
time fell 70% thanks to automated citation mapping and verifiable source trails
for every generated answer.

Why it Matters for Enterprises

Siloed institutional knowledge is a measurable drag on R&D velocity. Enterprises in
regulated, research-heavy sectors should evaluate GraphRAG architectures for
both speed gains and auditable compliance trails.

Tags

AWS, DrugDiscovery, GraphRAG, HealthcareAI, KnowledgeGraphs
Read More
LinkedIn Icon Facebook Icon YouTube Icon
info@rapidflowapps.com

Explore Rapidflow AI

An accelerator for your AI journey